Aligos Therapeutics
Price & Volume
Stats
See more52W Range | $3.98-$13.68 |
Market Cap | $34.4M |
Shares Short | 697,683 |
Financials
See moreRevenue (12 Mos) | $31.5M |
Revenue Growth (YoY) | 2,778.5% |
Gross Profit (12 Mos) | -$56.8M |
Diluted EPS | -$7.71 |
News
See moreYahoo Finance • 3 months ago
Aligos Secures $25M Upfront In Greater China HBV Deal; Stock Up
Yahoo Finance • 4 months ago
Aligos Presents Promising Data For Pevifoscovir Sodium In Treating Hepatitis B
Yahoo Finance • 4 months ago
Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
Yahoo Finance • 5 months ago
Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026
About
CEO | Dr. Lawrence M. Blatt MBA, Ph.D. |
CFO | Ms. Lesley Ann Calhoun CPA |
Address | One Corporate Drive, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 82 |